[(1S)-1-[5-chloro-4-oxo-3-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]quinazolin-2-yl]ethyl]carbamic acid
C17H18ClF3N4O3 — CID 118572369
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(1S)-1-[5-chloro-4-oxo-3-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]quinazolin-2-yl]ethyl]carbamic acid
[(1S)-1-[5-chloro-4-oxo-3-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]quinazolin-2-yl]ethyl]carbamic acid (PubChem CID 118572369) has the molecular formula C17H18ClF3N4O3 and a molecular weight of 418.80 g/mol. Its IUPAC name is [(1S)-1-[5-chloro-4-oxo-3-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]quinazolin-2-yl]ethyl]carbamic acid.
Molecular Properties
| Compound Name | [(1S)-1-[5-chloro-4-oxo-3-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]quinazolin-2-yl]ethyl]carbamic acid |
|---|---|
| PubChem CID | 118572369 |
| Molecular Formula | C17H18ClF3N4O3 |
| Molecular Weight | 418.80 g/mol |
| Exact Mass | 418.10 |
| IUPAC Name | [(1S)-1-[5-chloro-4-oxo-3-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]quinazolin-2-yl]ethyl]carbamic acid |
| SMILES | C[C@H](NC(=O)O)c1nc2cccc(Cl)c2c(=O)n1C1CCN(CC(F)(F)F)C1 |
| InChI | InChI=1S/C17H18ClF3N4O3/c1-9(22-16(27)28)14-23-12-4-2-3-11(18)13(12)15(26)25(14)10-5-6-24(7-10)8-17(19,20)21/h2-4,9-10,22H,5-8H2,1H3,(H,27,28)/t9-,10?/m0/s1 |
| InChIKey | IWURJGLPGHEPGK-RGURZIINSA-N |
| XLogP | 3.19 |
| TPSA | 87.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.80 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118572369 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.